Arena Pharmaceuticals Announces R&D Leadership Transition

Author's Avatar
Jun 09, 2020
Article's Main Image

- Dr. Preston Klassen, Executive Vice President, Head of Research and Development, resigning

- Dr. Chris Cabell appointed Executive Vice President, Head of Research and Development, and Chief Medical Officer

PR Newswire